Healthy financing opportunities.

LDC has invested more than £220m of equity capital to back more than 25 businesses across the healthcare industry over the last 35 years.

The UK healthcare and pharmaceuticals sector is thriving. Fundamental growth drivers, including an ageing population, increasing influence of technology and demand for homecare has created significant opportunity.

Our team has built an enviable track record in backing the growth ambitions of management teams from across the sector, with particular experience in the dynamic pharmaceutical and medical equipment sectors.

Having worked with management teams from Quantum Pharmaceutical, Synexus, Aesica Pharmaceuticals and Prism Medical UK to support their growth plans, LDC remains an active investor in the healthcare sector.

Recent Healthcare Transactions

  • Lucid Group Logo

    Lucid Group

    Lucid Group Communications is a specialist provider of strategic medical communications services to global pharmaceutical companies. 
    Type
    Development Capital
    Deal Size
    Less than £20m
    Entry Date
    12/06/2017
    Exit Date
    -
  • Fishawack Logo

    Fishawack

    Fishawack is a specialist provider of scientific communications services to global pharmaceutical companies.
    Type
    Management Buyout
    Deal Size
    £20m to £40m
    Entry Date
    25/01/2017
    Exit Date
    -